Your email has been successfully added to our mailing list.

×
-0.0198128783709411 -0.0198128783709411 -0.0198128783709411 -0.0198128783709411 -0.0198128783709411 -0.0198128783709411 -0.0198128783709411 -0.0198128783709411
Stock impact report

German competition regulator clears path for Novartis takeover of MorphoSys [Reuters]

MorphoSys AG - American Depositary Shares (MOR) 
Company Research Source: Reuters
MorphoSys (MORG.DE) , opens new tab , a developer of cancer treatments, by Switzerland's Novartis. (NOVN.S) , opens new tab "We checked very carefully that the merger would not affect competition for research and development of new drugs against a form of leukemia," Andreas Mundt, President of the Federal Cartel Office said. Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here. Reporting by Bartosz Dabrowski in Gdansk Editing by Madeline Chambers Our Standards: The Thomson Reuters Trust Principles. , opens new tab Show less Read more
Impact Snapshot
Event Time:
MOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MOR alerts
Opt-in for
MOR alerts

from News Quantified
Opt-in for
MOR alerts

from News Quantified